Crohn’s Patients Gain Quality of Life with New Treatment Plan
October 11, 2008 by MedHeadlines
Filed under Crohn's Disease
Researchers at the Mayo Clinic say the new therapeutic approach to Crohn’s disease they’ve developed brings more “opportunity for remission” and “significant improvement in quality of life” for the 500,000 Americans estimated to have this inflammatory disorder that affects the gastrointestinal tract. The research team presented its new approach earlier today at the 2008 annual meeting of the American College of Gastroenterology (ACG). Read more
FDA Investigates JIA, TNF Blockers, and Cancer in Children
June 4, 2008 by MedHeadlines
Filed under Adolescents, Cancer, Children's Health, Crohn's Disease, Drugs, FDA, Prevention, Rheumatoid Arthritis
The US Food and Drug Administration (FDA) has just announced an investigation into the link between certain drugs known as tumor necrosis factor (TNF) blockers and the development of cancer in children and young adults taking these medications. TNF blockers are routinely prescribed to children aged 18 and younger to treat conditions such as Juvenile Idiopathic Arthritis (JIA), formerly known as Juvenile Rheumatoid Arthritis (JRA), Crohn’s disease, and other diseases of the immune system. Read more
Loading ...
